GLP-1 Provider Red Flags: 7 Warning Signs Before You Sign Up
Hundreds of telehealth companies now offer GLP-1 programs. Most are legitimate. Some are not. The FDA has documented over 775 adverse events linked to compounded GLP-1s, many tied to providers that prioritize speed and volume over patient safety. Here's how to tell the difference.
Red Flag #1: No Medical History Review
GLP-1 receptor agonists are contraindicated in patients with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, and a history of pancreatitis. A provider that ships medication without asking about your medical history is putting you at risk.
What a good provider does: Requires a comprehensive health questionnaire, reviews your medical history, asks about current medications, and may require recent lab work before prescribing.
Red Flag #2: The "$99 First Month" Trick
Several providers advertise dramatically low first-month pricing that jumps 200-400% in month two. This isn't necessarily fraudulent — starting doses are genuinely cheaper — but the way it's marketed often obscures the true ongoing cost.
What to look for: Ask for a price schedule showing all dose levels before you sign up. If the provider can't or won't provide this, walk away.
Red Flag #3: No Prescriber Credentials Listed
You have the right to know who's prescribing your medication. Legitimate telehealth providers list their prescribers' credentials, state licenses, and medical board certifications.
What a good provider does: Names their medical directors, lists NPI numbers, and is transparent about whether prescriptions come from MDs, DOs, NPs, or PAs.
Red Flag #4: Can't Name Their Pharmacy
Every compounded GLP-1 comes from a pharmacy. If your provider can't tell you the name, license type (503A vs. 503B), and state of their compounding pharmacy, that's a significant trust issue.
Why it matters: 503B outsourcing facilities are FDA-inspected but face the proposed compounding ban. 503A pharmacies are state-regulated and compound individual prescriptions. You deserve to know which type your medication comes from.
Red Flag #5: Pressure to Prepay Multiple Months
Some providers push 3-6 month prepayment plans to "lock in pricing" before regulatory changes. While multi-month plans can offer genuine savings, aggressive upselling — especially framed around regulatory urgency — is a yellow flag.
Best practice: Pay month-to-month until you've confirmed the provider is legitimate and the medication works for you. If a provider won't let you start with a single month, consider why.
Red Flag #6: No Follow-Up Protocol
GLP-1 treatment requires ongoing clinical monitoring. Your provider should schedule check-ins during dose titration, ask about side effects, and adjust your plan based on your response.
Minimum standard: At least one check-in during the first month, follow-ups at each dose increase, and a clear process for reaching your prescriber if you experience adverse effects.
Red Flag #7: Guaranteed Results or Celebrity Endorsements
No legitimate medical provider guarantees specific weight loss outcomes. Individual results vary based on genetics, adherence, diet, exercise, and dozens of other factors. Providers that promise "30 pounds in 30 days" or feature unverifiable before-and-after transformations are marketing machines, not medical practices.
Providers We've Vetted
The following telehealth providers meet our minimum standards for medical oversight, pharmacy transparency, and pricing disclosure: